Ebola affecting tours to South Africa
22 October 2014 | By Frost & Sullivan
Etienne van Wyk, Programme Manager for Healthcare at Frost & Sullivan Africa, comments on the current outbreak and its long term implications...
List view / Grid view
News
Boehringer Ingelheim initiates global Phase III study investigating nintedanib* in patients with colorectal cancer refractory to standard treatments
21 October 2014 | By Boehringer Ingelheim
Boehringer Ingelheim today announced the enrolment of the first patient in a new global Phase III study in patients with advanced colorectal cancer...
Sartorius grows in order intake, sales revenue and earnings
Sartorius, a leading international laboratory and pharmaceutical equipment supplier, successfully closed the first nine months of 2014 with substantial gains.
Calixar and Aston University together in collaborative research to tackle multidrug resistance targets
21 October 2014 | By Calixar
Aston University (Birmingham - UK) and Calixar SAS (Lyon-France) have concluded a new research agreement through the “BBSRC Industrial CASE Studentship Competition 2013” framework...
Amgen announces appointment of R. Sanders Williams to Board of Directors
21 October 2014 | By Amgen
Amgen announced the appointment of R. Sanders Williams, M.D., president of Gladstone Institutes and Gladstone's Robert W. and Linda L. Mahley Distinguished Professor...
Speeding up development of Ebola treatments and vaccines
21 October 2014 | By The European Medicines Agency
EMA encourages companies to apply for orphan designation...
Demos: Migrant health access fears put vulnerable people at risk
20 October 2014 | By Doctors of the World UK
A new report by the think-tank Demos, supported by Doctors of the World, argues that encouraging earlier detection of health conditions amongst migrant communities would reduce NHS spending on treatment and reduce the wider public health risk by catching transmittable diseases early...
Small businesses pitch for £2.5 million funding as SBRI Healthcare launches new competition
20 October 2014 | By SBRI Healthcare
Funding will accelerate development and NHS adoption of new technologies...
Masters Speciality Pharma – celebrating 30 years in business
20 October 2014 | By Masters Speciality Pharma
Masters Speciality Pharma celebrates the anniversary of its foundation by Dr Zulf Masters, OBE, 30 years ago...
European Commission approves IMBRUVICA in two forms of blood cancer
20 October 2014 | By Janssen
Janssen-Cilag International NV (Janssen) announced today that the European Commission has approved IMBRUVICA™ (ibrutinib) capsules, a first-in-class, once-daily, oral Bruton’s tyrosine kinase (BTK) inhibitor.
Abbott acknowledged by Science Magazine as a top employer
20 October 2014 | By Abbott
Abbott was named one of the Top 20 Employers by the journal Science...
Nasdaq welcomes Forward Pharma A/S (Nasdaq: FWP) to The Nasdaq Stock Market
20 October 2014 | By Nasdaq
Nasdaq announced that trading of Forward Pharma A/S (Nasdaq: FWP) commenced on The Nasdaq Stock Market on October 15, 2014....
AstraZeneca strengthens partnership with the University of Cambridge
20 October 2014 | By AstraZeneca
AstraZeneca, together with its global biologics research and development arm, MedImmune, announced that it has entered into four new collaborations with the University of Cambridge, building further on their existing partnership...
METTLER TOLEDO’s XS Balance line delivers performance and ergonomics to safeguard health in the workplace
16 October 2014 | By METTLER TOLEDO
The extended and improved XS balance line incorporates patented weighing technologies to ensure accurate results whilst ergonomic design features provide outstanding comfort to protect user health during daily weighing tasks.
METTLER TOLEDO launch new XPE Balance portfolio designed for performance and ease of compliance
16 October 2014 | By METTLER TOLEDO
The new line of XPE balances focuses on delivering accurate, compliant results and provides users with a high level of process security, suitable for even the strictest regulations...
